Literature DB >> 10915759

The TSC1 gene product, hamartin, negatively regulates cell proliferation.

A Miloloza1, M Rosner, M Nellist, D Halley, G Bernaschek, M Hengstschläger.   

Abstract

Tuberous sclerosis is an autosomal dominant hereditary disease caused by mutations in either the TSC1 or the TSC2 tumor suppressor gene. The TSC1 gene on chromosome 9q34 encodes a 130 kDa protein named hamartin, and the TSC2 gene on chromosome 16p13.3 codes for tuberin, a 200 kDa protein. Here we show that expression of hamartin, assayed by immunoblot analyses, is high in G(0)-arrested cells and hamartin is expressed throughout the entire ongoing cell cycle. An interaction of hamartin and tuberin can be detected in every phase of the cell cycle. Ectopic expression of high levels of hamartin attenuates cellular proliferation. We provide evidence that this effect could depend on a coiled-coil region earlier proposed to be involved in binding of hamartin to tuberin. Further investigations revealed that hamartin affects cell proliferation via deregulation of G(1) phase. Our data have a clear impact on understanding the role of hamartin during development of this disease.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10915759     DOI: 10.1093/hmg/9.12.1721

Source DB:  PubMed          Journal:  Hum Mol Genet        ISSN: 0964-6906            Impact factor:   6.150


  14 in total

1.  Tuberin--a new molecular target in Alzheimer's disease?

Authors:  Rosa Ferrando-Miguel; Margit Rosner; Angelika Freilinger; Gert Lubec; Markus Hengstschläger
Journal:  Neurochem Res       Date:  2005-11       Impact factor: 3.996

2.  Lactic Acid Accumulation in the Tumor Microenvironment Suppresses 18F-FDG Uptake.

Authors:  Silvan Türkcan; Louise Kiru; Dominik J Naczynski; Laura S Sasportas; Guillem Pratx
Journal:  Cancer Res       Date:  2018-12-03       Impact factor: 12.701

3.  Neural Crest-Specific TSC1 Deletion in Mice Leads to Sclerotic Craniofacial Bone Lesion.

Authors:  Fang Fang; Shaogang Sun; Li Wang; Jun-Lin Guan; Marco Giovannini; Yuan Zhu; Fei Liu
Journal:  J Bone Miner Res       Date:  2015-07       Impact factor: 6.741

Review 4.  Tuberous sclerosis complex: a review of the management of epilepsy with emphasis on surgical aspects.

Authors:  Mary B Connolly; Glenda Hendson; Paul Steinbok
Journal:  Childs Nerv Syst       Date:  2006-06-13       Impact factor: 1.475

5.  Merging high-quality biochemical fractionation with a refined flow cytometry approach to monitor nucleocytoplasmic protein expression throughout the unperturbed mammalian cell cycle.

Authors:  Margit Rosner; Katharina Schipany; Markus Hengstschläger
Journal:  Nat Protoc       Date:  2013-02-28       Impact factor: 13.491

6.  Tuberous sclerosis complex-1 and -2 gene products function together to inhibit mammalian target of rapamycin (mTOR)-mediated downstream signaling.

Authors:  Andrew R Tee; Diane C Fingar; Brendan D Manning; David J Kwiatkowski; Lewis C Cantley; John Blenis
Journal:  Proc Natl Acad Sci U S A       Date:  2002-09-23       Impact factor: 11.205

Review 7.  Role of TSC1 in physiology and diseases.

Authors:  Karthik Mallela; Arun Kumar
Journal:  Mol Cell Biochem       Date:  2021-02-11       Impact factor: 3.396

8.  Identification of FIP200 interaction with the TSC1-TSC2 complex and its role in regulation of cell size control.

Authors:  Boyi Gan; Zara K Melkoumian; Xiaoyang Wu; Kun-Liang Guan; Jun-Lin Guan
Journal:  J Cell Biol       Date:  2005-07-25       Impact factor: 10.539

9.  TSC1 controls distribution of actin fibers through its effect on function of Rho family of small GTPases and regulates cell migration and polarity.

Authors:  Maki Ohsawa; Toshiyuki Kobayashi; Hidehiro Okura; Takashi Igarashi; Masashi Mizuguchi; Okio Hino
Journal:  PLoS One       Date:  2013-01-23       Impact factor: 3.240

10.  Cytotoxic effect of 5-aminoimidazole-4-carboxamide-1-beta-4-ribofuranoside (AICAR) on childhood acute lymphoblastic leukemia (ALL) cells: implication for targeted therapy.

Authors:  Tapas K Sengupta; Gilles M Leclerc; Ting Ting Hsieh-Kinser; Guy J Leclerc; Inderjit Singh; Julio C Barredo
Journal:  Mol Cancer       Date:  2007-07-10       Impact factor: 27.401

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.